Header image
 
 
 
 
 
 
 
Publications

Publications by year:2016 | 2015 | 2014 |2013 |2012 |2011 | 2010 | 2009 | 2008 | Before UW-Madison

2016

11:05 AM 6/27/2016
195 Zhang Y, Wang D, Goel S, Geng J, Sun H, Barnhart TE, Cai W, Xia J, Lovell JF. Surfactant-stripped edible frozen pheophytin micelles for multimodal gut imaging. Advanced Materials, 2016, revision.
194 Im H-J, England CG, Feng L, Graves SA, Hernandez R, Nickles RJ, Liu Z, Lee DS, Cho SY, Cai W. Accelerated blood clearance phenomenon reduces the passive targeting of PEGylated nanoparticles in peripheral arterial disease. ACS Applied Materials & Interfaces, 2016, revision.
193 Sun H, England CG, Hernandez R, Graves SA, Majewski RL, Kamkaew A, Jiang D, Barnhart TE, Yang Y, Cai W. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer. European Journal of Nuclear Medicine and Molecular Imaging, 2016, in press. (NIHMSID 793722)
192 Brunnquell CL, Hernandez R, Graves SA, Smit-Oistad I, Nickles RJ, Cai W, Meyerand ME, Suzuki M. Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain. Contrast Media & Molecular Imaging, 2016, in press.
191 Lu W, Hong H, Cai W. Radio-nanomaterials for biomedical applications: state of the art. European Journal of Nanomedicine, 2016, ePub. (NIHMSID 788416)
190 England CG, Ehlerding EB, Cai W. Imaging the biodistribution and performance of transplanted stem cells with PET. Journal of Nuclear Medicine, 2016, ePub. (NIHMSID 777822)
189 Luo H, England CG, Shi S, Graves SA, Hernandez R, Yang Y, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W. Dual-targeting of tissue factor and CD105 for preclinical PET imaging of pancreatic cancer. Clinical Cancer Research, 2016, ePub. (NIHMSID 774534)
188 Xu C, Shi S, Feng L, Chen F, Graves SA, Goel S, Ehlerding EB, Sun H, England CG, Nickles RK, Liu Z, Wang T, Cai W. Long Circulating Reduced Graphene oxide/Fe3O4 Nanocomposite with Double PEGylation for Highly Efficient Tumor Targeting and Multimodal Imaging. Nanoscale, 2016, ePub. (NIHMSID 774532)
187 Ai F, Ferreira CA, Chen F, Cai W. Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. Wiley Interdisciplinary Reviews (WIREs): Nanomedicine and Nanobiotechnology. 2016, ePub. (NIHMSID 741463)
186 Goel S, Chen F, Luan S, Valdovinos HF, Shi S, Graves SA, Ai F, Barnhart TE, Theuer CP, Cai W. Engineering intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo biodistribution and tumor targeting studies. Advanced Science, 2016, 3, 1600122. (NIHMSID 792783)
185 England CG, Im H-J, Feng L, Chen F, Graves SA, Hernandez R, Orbay H, Xu C, Cho SY, Nickles RJ, Liu Z, Lee DS, Cai W. Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles. Biomaterials, 2016, 100, 101-109. (NIHMSID 788413)
184 England CG, Kamkaew A, Im H-J, Valdovinos HF, Sun H, Hernandez R, Cho SY, Dunphy EJ, Lee DS, Barnhart TE, Cai W. ImmunoPET imaging of insulin-like growth factor 1 receptor in a subcutaneous mouse model of pancreatic cancer. Molecular Pharmaceutics, 2016, 13, 1958-1966. (NIHMSID 776684) (Selected as ACS Editors’ Choice for Immediate Open Access)
183 Ehlerding EB, Chen F, Cai W. Biodegradable and renal clearable inorganic nanoparticles. Advanced Science, 2016, 3, 1500223. (NIHMSID 792775)
182 Kamkaew A, Sun H, England CG, Cheng L, Liu Z, Cai W. Quantum dot – NanoLuc bioluminescence resonance energy transfer enables tumor imaging and lymph node mapping in vivo. Chemical Communications, 2016, 52, 6997-7000. (NIHMSID 785343)
181 Kamkaew A, Chen F, Zhan Y, Majewski RL, Cai W. Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy. ACS Nano, 2016, 10, 3918-3935. (PMCID: PMC4846476)
180 England CG, Ehlerding EB, Cai W. NanoLuc: A small luciferase is brightening up the field of bioluminescence. Bioconjugate Chemistry, 2016, 27, 1175-1187. (PMCID: PMC4871753)
179 Chen F, Goel S, Hernandez R, Graves SA, Shi S, Nickles RJ, Cai W. Dynamic positron emission tomography imaging of renal clearable gold nanoparticles. Small, 2016, 12, 2775-2782. (PMCID: PMC4874869)
178 Zhan Y, Ai F, Chen F, Valdovinos HF, Orbay H, Sun H, Liang J, Barnhart TE, Tian J, Cai W. Intrinsically zirconium-89 labeled Gd2O2S:Eu nanoprobes for in vivo positron emission tomography and Gamma-ray-induced radioluminescence imaging. Small, 2016, 12, 2872-2876. (PMCID: PMC4889465)
177 Ehlerding EB, Cai W. Smaller agents for larger therapeutic indices: nanoscale brachytherapy with 177Lu-labeled gold nanoparticles. Journal of Nuclear Medicine, 2016, 57, 834-835. (PMCID: PMC4891258)
176 Ehlerding EB, Goel S, Cai W. Cancer theranostics with 64Cu/177Lu-loaded liposomes.  European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43, 938-940. (PMCID: PMC4814333)
175 Cheng L, Shen S, Shi S, Yi Y, Wang X, Song G, Yang K, Liu G, Barnhart TE, Cai W, Liu Z. FeSe2-decorated Bi2Se3 nanosheets fabricated via cation exchange for chelator-free 64Cu-labeling and multimodal image-guided photothermal-radiation therapy. Advanced Functional Materials, 2016, 26, 2185-2197. (PMCID: PMC4838545)
174 Ellison PA, Barnhart TE, Chen F, Hong H, Zhang Y, Theuer CP, Cai W, Nickles RJ, DeJesus OT. High yield production and radiochemical isolation of isotopically pure arsenic-72 and novel radioarsenic labeling strategies for the development of theranostic radiopharmaceuticals. Bioconjugate Chemistry, 2016, 27, 179-188. (PMCID: PMC4720530)
173 England CG, Hernandez R, Eddine SBZ, Cai W. Molecular imaging of pancreatic cancer with antibodies. Molecular Pharmaceutics, 2016, 13, 8-24. (PMCID: PMC4701613)
172 Rhode PR, Egan JO, Xu W, Hong H, Webb GM, Chen X, Liu B, Zhu X, Wen J, You L, Kong L, Edwards AC, Han K, Shi S, Alter S, Sacha JB, Jeng EK, Cai W, Wong HC. Comparison of the superagonist complex, ALT-803, to IL15 as cancer immunotherapeutics in animal models. Cancer Immunology Research, 2016, 4, 49-60. (PMCID: PMC4703482)(Cover Feature)
171 Ehlerding EB, Cai W. Harnessing the power of molecular imaging for precision medicine. Journal of Nuclear Medicine, 2016, 57, 171-172. (PMCID: PMC4738016)
170 Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W. PET imaging of VEGFR-2 expression in lung cancer with 64Cu-labeled ramucirumab. Journal of Nuclear Medicine, 2016, 57, 285-290.(PMCID: PMC4738068)
169 Huang H, Hernandez R, Geng J, Sun H, Song W, Chen F, Graves SA, Nickles RJ, Cheng C, Cai W, Lovell JF. A porphyrin-PEG polymer with rapid renal clearance. Biomaterials, 2016, 76, 25-32. (PMCID: PMC4662896)

2015

168 Yang Y, Hernandez R, Rao J, Yin L, Qu Y, Wu J, England CG, Graves SA, Lewis CM, Wang P, Meyerand ME, Nickles RJ, Bian XW, Cai W. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas. Proceedings of the National Academy of Sciences of the United States of America, 2015, 112, E6525-E6534. (PMCID: PMC4664343)
167 Luo H, Hernandez R, Hong H, Graves SA, Yang Y, England CG, Theuer CP, Nickles RJ, Cai W. Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry. Proceedings of the National Academy of Sciences of the United States of America. 2015, 112, 12806-12811. (PMCID: PMC4611632)
166 Shi S, Fliss BC, Gu Z, Zhu Y, Hong H, Valdovinos HF, Hernandez R, Goel S, Luo H, Chen F, Barnhart TE, Nickles RJ, Xu ZP, Cai W. Chelator-free labeling of layered double hydroxide nanoparticles for in vivo PET imaging. Scientific Reports, 2015, 5, 16930. (PMCID: PMC4653656)
165 Graves SA, Hernandez R, Fonslet J, England CG, Valdovinos HF, Ellison PA, Barnhart TE, Elema DR, Theuer CP, Cai W, Nickles RJ, Severin GW. Novel preparation methods of 52Mn for immunoPET imaging. Bioconjugate Chemistry, 2015, 26, 2118-2124. (PMCID: PMC4618027)
164 Chen F, Goel S, Valdovinos HF, Luo H, Hernandez R, Barnhart TE, Cai W. Chelator-free 89Zr-labeling of mesoporous silica nanoparticles with superb in vivo radio-stability. ACS Nano, 2015, 9, 7950-7959. (PMCID: PMC4550540)
163 Sun X, Cai W, Chen X. Positron emission tomography imaging using radiolabeled inorganic nanomaterials. Accounts of Chemical Research, 2015, 48, 286-294. (PMCID: PMC4540359)
162 Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, Hernandez R, Luo H, Goel S, Theuer CP, Nickles, RJ, Cai W. PET imaging of abdominal aortic aneurysm with a 64Cu-labeled antibody Fab fragment. Journal of Nuclear Medicine, 22015, 56, 927-932. (PMCID: PMC4452422)
161 Hernandez R, Czerwinski A, Chakravarty R, Yang Y, Graves SA, Nickles RJ, Cai W. Evaluation of two novel 64Cu-labelled RGD peptide derivatives for enhanced PET imaging of tumor integrin αvβ3. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42, 1859-1868. (PMCID: PMC4591102)
160 Shi S, Hong H, Orbay H, Graves SA, Yang Y, Ohman JD, Liu B, Nickles RJ, Wong HC, Cai W. ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42, 1295-1303. (PMCID: PMC4482783)
159 Chakravarty R, Hong H, Cai W. Image-guided drug delivery with single-photon emission computed tomography: A review of literature. Current Drug Targets, 2015, 16, 592-609. (PMCID: PMC4346511)
158 England CG, Luo H, Cai W. HaloTag: a versatile platform for biomedical applications. Bioconjugate Chemistry, 2015, 26, 975-986. (PMCID: PMC4482335)
157 Dougherty CA, Cai W, Hong H. Applications of aptamers in targeted imaging: State of the art. Current Topics in Medicinal Chemistry, 2015, 15, 1138-1152. (PMCID: PMC4410081)
156 Chen F, Hong H, Goel S, Graves SA, Orbay H, Ehlerding EB, Shi S, Theuer CP, Nickles RJ, Cai W. In vivo tumor vasculature targeting of CuS@MSN based theranostic nanomedicine. ACS Nano, 2015, 9, 3926-3934. (PMCID: PMC4414921)
155 Liu T, Shi S, Liang C, Shen S, Cheng L, Wang C, Song X, Goel S, Barnhart TE, Cai W, Liu Z. Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy. ACS Nano, 2015, 9, 950-960. (PMCID: PMC4351725)
154 Hong H, Wang F, Zhang Y, Graves SA, Eddine SBZ, Yang Y, Theuer CP, Nickles RJ, Wang X, Cai W. Red fluorescent zinc oxide nanoparticle: A novel platform for cancer targeting. ACS Applied Materials & Interfaces, 2015, 7, 3373-3381. (PMCID:  PMC4326560)
153 Hong H, Yan Y, Shi S, Graves SA, Krasteva LK, Nickles RJ, Yang M, Cai W. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. Molecular Pharmaceutics, 2015, 12, 403-410. (PMCID: PMC4351720)
152 Rieffel J, Chen F, Kim J, Chen G, Shao W, Shao S, Chitgupi U, Hernandez R, Graves SA, Nickles RJ, Prasad PN, Kim C, Cai W, Lovell JF. Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles. Advanced Materials, 2015, 27, 1785-1790. (PMCID: PMC4416944)
151 Chen F, Cai W. Nanomedicine for targeted photothermal cancer therapy: where are we now? Nanomedicine, 2015, 10, 1-3. (PMCID: PMC4299941)
150 Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W. PET of c-Met in cancer with 64Cu-labeled hepatocyte growth factor. Journal of Nuclear Medicine, 2015, 56, 758-763. (PMCID: PMC4417426)
149 Chakravarty R, Goel S, Hong H, Chen F, Valdovinos HF, Hernandez R, Barnhart TE, Cai W. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery. Nanomedicine, 2015, 10, 1233-1246. (PMCID: PMC4430331)
148 Valdovinos HF, Hernandez R, Barnhart TE, Graves S, Cai W, Nickles RJ. Separation of cyclotron-produced 44Sc from a natural calcium target using a dipentyl pentylphosphonate functionalized extraction resin. Applied Radiation and Isotopes, 2015, 95, 23-29. (PMCID: PMC4390433)
147 Lewis CM, Graves SA, Hernandez R, Valdovinos HF, Barnhart TE, Cai W, Meyerand ME, Nickles RJ, Suzuki M. 52Mn production for PET/MRI tracking of human stem cells expressing divalent metal transporter 1 (DMT1). Theranostics, 2015, 5, 227-239. (PMCID: PMC4279187)
146 Shi S, Yang K, Hong H, Chen F, Valdovinos HF, Goel S, Barnhart TE, Liu Z, Cai W. VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. Biomaterials, 2015, 39, 39-46. (PMCID: PMC4258896)

2014

145 Chen F, Ehlerding EB, Cai W. Theranostic Nanoparticles.Journal of Nuclear Medicine. 2014, 55, 1919-1922. (PMCID: PMC4255955)
144 Chakravarty R, Goel S, Valdovinos HF, Hernandez R, Hong H, Nickles RJ, Cai W. Matching the decay half-life with the biological half-life: ImmunoPET imaging with 44Sc-labeled cetuximab Fab fragment. Bioconjugate Chemistry, 2014, 25, 2197-2204. (PMCID: PMC4275156)
143  Shi S, Chen F, Ehlerding EB, Cai W. Surface engineering of graphene-based nanomaterials for biomedical applications.Bioconjugate Chemistry, 2014, 25, 1609-1619. (PMCID: PMC4166029)
142 Guo J,* Hong H,* Chen G, Shi S, Nayak TR, Theuer CP, Barnhart TE, Cai W, Gong S. Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging. ACS Applied Materials & Interfaces, 2014, 6, 21769-21779. (PMCID: PMC4163544)
141
Zhang Y, Jeon M, Rich LJ, Hong H, Geng J, Zhang Y, Shi S, Barnhart TE, Alexandridis P, Huizinga JD, Seshadri M, Cai W, Kim C, Lovell JF. Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines. Nature Nanotechnology, 2014, 9, 631-638. (Highlighted in Science Translational Medicine, Chemical & Engineering News, Nature World News, Science World Report, Science Daily, and many other news media) (PMCID: PMC4130353)
140
Hong H,* Chen F,* Zhang Y, Cai W. New radiotracers for imaging of vascular targets in angiogenesis-related diseases. Advanced Drug Delivery Reviews, 2014, 76, 2-20. (PMCID: PMC4169744)
139
Hernandez R, Valdovinos HF, Yang Y, Chakravarty R, Hong H, Barnhart TE, Cai W. 44Sc: an attractive isotope for peptide-based PET imaging, Molecular Pharmaceutics, 2014, 11, 2954-2961. (PMCID: PMC4128785)
138
Hong H, Nayak TR, Shi S, Graves SA, Fliss BC, Barnhart TE, Cai W. Generation and screening of monoclonal antibodies for immunoPET imaging of IGF1R in prostate cancer. Molecular Pharmaceutics, 2014, 11, 3624-3630. (PMCID: PMC4186682)
137
Chakravarty R, Valdovinos HF, Chen F, Lewis CM, Ellison PA, Luo H, Meyerand ME, Nickles RJ, Cai W. Intrinsically germanium-69-labeled iron oxide nanoparticle: synthesis and in-vivo dual-modality PET/MR imaging. Advanced Materials, 2014, 26, 5119-5123. (PMCID: PMC4127144)
136 Chen F,* Hong H,* Shi S, Goel S, Valdovinos HF, Hernandez R, Theuer CP, Barnhart TE, Cai W. Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy. Scientific Reports, 2014, 4, 5080. (PMCID: PMC4038837)
135
Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP, Barnhart TE, Cai W. In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles. Molecular Pharmaceutics, 2014, 11, 4007−4014. (PMCID: PMC4218929)
134
Goel S, Chen F, Ehlerding EB, Cai W. Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small, 2014, 10, 3825-3830. (Selected as Frontispiece) (PMCID: PMC4191998)
133 Chakravarty R, Hong H, Cai W. Positron emission tomography image-guided drug delivery: current status and future perspectives. Molecular Pharmaceutics, 2014, 11, 3777−3797. (PMCID: PMC4218872)
132
Luo H, Hong H, Yang SP, Cai W. Design and applications of bispecific heterodimers: molecular imaging and beyond.Molecular Pharmaceutics, 2014, 11, 1750-1761. (PMCID: PMC4051252
131  Goel S, Chen F, Hong H, Valdovinos HF, Hernandez R, Shi S, Barnhart TE, Cai W. VEGF121-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system. ACS Applied Materials & Interfaces, 2014, 6, 21677-21685. (PMCID: PMC4262629)
130 Chen F, Cai W. Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials. Small, 2014, 10, 1887-1893. (PMCID: PMC4126500)
129
Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, Wisinski KB, Huang W, Cai W, Pike JW, Yuan M, Ahlquist P, Xu W. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell, 2014, 25, 21-36. (PMCID: PMC4004525)
128
Chakravarty R, Goel S, Cai W. Nanobody: The “magic bullet” for molecular imaging? Theranostics, 2014, 4, 386-398. (PMCID: PMC3936291)
127
Orbay H, Zhang Y, Valdovinos HF, Song G, Hernandez R, Theuer CP, Hacker TA, Nickles RJ, Cai W. Positron emission tomography imaging of CD105 expression in a rat myocardial infarction model with 64Cu-NOTA-TRC105. American Journal of Nuclear Medicine and Molecular Imaging, 2014, 4, 1-9. (PMCID: PMC3867724)
126
Orbay H, Hong H, Koch JM, Valdovinos HF, Hacker TA, Theuer CP, Barnhart TE, Cai W. Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with 64Cu-NOTA-TRC105. American Journal of Translational Research, 2014, 6, 54-63. (PMCID: PMC3853424)
125
Goel S, Chen F, Cai W. Synthesis and biomedical applications of cupper sulfide nanoparticles: from sensors to theranostics. Small, 2014, 10, 631-645. (PMCID: PMC3960363)

 

2013

124
Orbay H, Bean J, Zhang Y, Cai W. Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery. Current Pharmaceutical Biotechnology, 2013, 14, 733-742. (PMCID: PMC3946701)
123
Chen F,* Ellison PA,* Lewis CM, Hong H, Zhang Y, Shi S, Hernandez R, Meyerand ME, Barnhart TE, Cai W. Chelator-free synthesis of a dual-modality PET/MRI agent. Angewandte Chemie International Edition,2013, 52, 13319-13323. (Highly Important Paper) (PMCID: PMC3855680)
122
Chen F,* Hong H,* Zhang Y, Valdovinos HF, Shi S, Kwon GS, Theuer CP, Barnhart TE, Cai W. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano, 2013, 7, 9027-9039. (PMCID: PMC3834886)
121
Yang K, Feng L, Hong H, Cai W, Liu Z. Preparation and functionalization of graphene nanocomposites for biomedical applications. Nature Protocols, 2013, 8, 2392-2403. (PMCID: PMC3878091)
120
Chen F, Zhang Y, Cai W. Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity. American Journal of Nuclear Medicine and Molecular Imaging, 2013, 3, 312-316. (PMCID: PMC3715775)
119
Shi S,* Chen F,* Cai W. Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging. Nanomedicine, 2013, 8, 2027-2039. (PMCID: PMC3844935)
118
Chen F, Bu W, Cai W, Shi J. Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research. Current Molecular Medicine, 2013, 13, 1613-1632. (PMCID: PMC3845686)
117
Zhang Y, Nayak TR, Hong H, Cai W. Biomedical applications of zinc oxide nanomaterials. Current Molecular Medicine, 2013, 13, 1633-1645. (PMCID: PMC3838497)
116
Nayak TR, Hong H, Zhang Y, Cai W. Multimodality imaging of CXCR4 in cancer: current status towards clinical translation. Current Molecular Medicine, 2013, 13, 1538-1548. (PMCID: PMC3838476)
115
Wang RE, Zhang Y, Tian L, Cai W, Cai J. Antibody-based imaging of HER2: moving into the clinic. Current Molecular Medicine, 2013, 13, 1523-1537. (PMCID: PMC3852915)
114
Zhu Y, Hong H, Xu ZP, Li Z, Cai W. Quantum dot-based nanoprobes for in vivo targeted imaging. Current Molecular Medicine, 2013, 13, 1549-1567. (PMCID: PMC3838460)
113
Guo J,* Hong H,* Chen G, Shi S, Zheng Q, Zhang Y, Theuer CP, Barnhart TE, Cai W, Gong S. Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. Biomaterials, 2013, 34, 8323-8332. (PMCID: PMC3785312)
112
Orbay H, Hong H, Zhang Y, Cai W. Positron emission tomography imaging of atherosclerosis. Theranostics, 2013, 3, 894-902. ( hrefPMCID: PMC3841339)
111
Orbay H,* Zhang Y,* Hong H, Hacker TA, Zegzebski JA, Theuer CP, Barnhart TE, Cai W. Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105. Molecular Pharmaceutics, 2013, 10, 2749-2756. (PMID: PMC3836864)
110
Hong H,* Chen F,* Cai W. Pharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dots. Molecular Imaging and Biology, 2013, 15, 507-520. (PMCID: PMC3773279)
109
Nayak TR, Krasteva LK, Cai W. Multimodality imaging of RNA interference. Current Medicinal Chemistry, 2013, 20, 3664-3675. (PMCID: PMC3749287)
108
Hernandez R, Orbay H, Cai W. Molecular imaging strategies for in vivo tracking of microRNAs: a comprehensive review. Current Medicinal Chemistry, 2013, 20, 3594-3603. (PMCID: PMC3749288)
107
Zhang Y, Hong H, Nayak TR, Valdovinos HF, Myklejord DV, Theuer CP, Barnhart TE, Cai W. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence. Angiogenesis, 2013, 16, 663-674. ( PMCID: PMC3706271)
106
Hafeez BB, Zhong W, Fischer JW, Mustafa A, Shi X, Meske L, Hong H, Cai W, Havighurst T, Kim KM, Verma AK. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model. Molecular Oncology, 2013, 7, 428-439. (PMCID: PMC3625495)
105
Shi S, Yang K, Hong H, Valdovinos HF, Nayak TR, Zhang Y, Theuer CP, Barnhart TE, Liu Z, Cai W. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials, 2013, 34, 3002-3009. (PMCID: PMC3570619)
104
Hong H,* Zhang Y,* Orbay H, Nayak TR, Valdovinos HF, Bean J, Theuer CP, Barnhart TE, Cai W. Positron emission tomography imaging of tumor angiogenesis with a 61/64Cu-labeled F(ab’)2 antibody fragment. Molecular Pharmaceutics, 2013, 10, 709-716. (PMCID: PMC3563848)
103
Hong H, Benink HA, Uyeda HT, Valdovinos HF, Zhang Y, Meisenheimer P, Barnhart TE, Fan F, Cai W. HaloTag as a reporter gene: positron emission tomography imaging with 64Cu-labeled second generation HaloTag ligands. American Journal of Translational Research, 2013, 5, 291-302. (PMCID: PMC3633972)
102
Zhang Y,* Hong H,* Orbay H, Nayak TR, Valdovinos HF, Theuer CP, Barnhart TE, Cai W. PET imaging of CD105/endoglin expression with a 61/64Cu-labeled Fab antibody fragment. European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, 759-767. (PMCID: PMC3625465)
101
Orbay H, Hong H, Zhang Y, Cai W. PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow. Angiogenesis, 2013, 16, 279-287. (PMCID: PMC3596452)

 

2012

100 Zhang Y,* Hong H,* Niu G, Valdovinos HF, Orbay H, Nayak TR, Chen X, Barnhart TE, Cai W. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with 61Cu-labeled lysine-tagged VEGF121. Molecular Pharmaceutics, 2012, 9, 3586-3594. (PMCID: PMC3619014)
99 Zhang Y,* Hong H,* Severin GW, Engle JW, Yang Y, Goel S, Nathanson AJ, Liu G, Nickles RJ, Leigh BR, Barnhart TE, Cai W. ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. American Journal of Translational Research, 2012, 4, 333-346. (PMCID: PMC3426387)
98 Xiao Y, Hong H, Matson VZ, Javadi A, Xu W, Yang Y, Zhang Y, Engle JW, Nickles RJ, Cai W, Steeber DA, Gong S. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics, 2012, 2, 757-768. (PMCID: PMC3425121)
97 Hong H,* Zhang Y,* Severin GW, Yang Y, Engle JW, Niu G, Nickles RJ, Chen X, Leigh BR, Barnhart TE, Cai W. Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. Molecular Pharmaceutics, 2012, 9, 2339-2349. (PMCID: PMC3500677)
96 Zhang Y,* Nayak TR,* Hong H, Cai W. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale, 2012, 4, 3833-3842. (PMCID: PMC3376191)
95 Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W. ImmunoPET of tissue factor in pancreatic cancer. Journal of Nuclear Medicine, 2012, 53, 1748-1754. (PMCID: PMC3489969)
94 Engle JW,* Hong H,* Zhang Y, Valdovinos HF, Myklejord DV, Barnhart TE, Theuer CP, Nickles, RJ, Cai W. Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody. Molecular Pharmaceutics, 2012, 9, 1441-1448. (PMCID: PMC3375902)
93 Yang Y,* Niu Y,* Hong H, Wu H, Zhang Y, Engle JW, Barnhart TE, Cai J, Cai W. Radiolabeled γ-AApeptides: a new class of tracers for positron emission tomography. Chemical Communications, 2012, 48, 7850-7852. (PMCID: PMC3397393)
92 Zhang Y, Cai W. Molecular imaging of insulin-like growth factor 1 receptor in cancer. American Journal of Nuclear Medicine and Molecular Imaging, 2012, 2, 248-259. (PMCID: PMC3477732)
91 Cai W, Hong H. In a “nutshell”: intrinsically radio-labeled quantum dots. American Journal of Nuclear Medicine and Molecular Imaging, 2012, 2, 136-140. (PMCID: PMC3477731)
90 Hong H,* Zhang Y,* Engle JW, Nayak TR, Theuer CP, Nickles RJ, Barnhart TE, Cai W. In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene. Biomaterials, 2012, 33, 4147-4156. (PMCID: PMC3313015)
89 Zhang Y,* Hong H,* Engle JW, Yang Y, Theuer CP, Barnhart TE, Cai W. Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. Molecular Pharmaceutics, 2012, 9, 645-653. (PMCID: PMC3295892)
88 Hong H,* Yang K,* Zhang Y, Engle JW, Feng L, Yang Y, Nayak TR, Goel S, Bean J, Theuer CP, Barnhart TE, Liu Z, Cai W. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nano-graphene. ACS Nano, 2012, 6, 2361-2370. (PMCID: PMC3314116) (Highlighted in Chemical & Engineering News)
87 Xiao Y,* Hong H,* Javadi A, Engle JW, Xu W, Yang Y, Zhang Y, Barnhart TE, Cai W, Gong S. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials, 2012, 33, 3071-3082. (PMCID: PMC3313838)
86 Zhang Y, Hong H, Engle JW, Yang Y, Barnhart TE, Cai W. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. American Journal of Nuclear Medicine and Molecular Imaging, 2012, 1, 1-13. (PMCID: PMC3249831)
85 Hong H, Severin GW, Yang Y, Engle JW, Zhang Y, Barnhart TE, Liu G, Leigh BR, Nickles RJ, Cai W. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 138-148. (PMCID: PMC3228902)

 

2011

84
Zhang Y, Hong H, Engle JW, Bean J, Yang Y, Leigh BR, Barnhart TE, Cai W. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled antibody: NOTA is superior to DOTA. PLoS ONE, 2011, 6, e28005. (PMCID: PMC3235104)
83
Hong H, Shi J, Yang Y, Zhang Y, Engle JE, Nickles NJ, Wang X, Cai W. Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Letters, 2011, 11, 3744-3750. (PMCID: PMC3173586)
82
Zhang Y, Hong H, Myklejord DV, Cai W. Molecular imaging with SERS-active nanoparticles. Small, 2011, 7, 3261-3269. (PMCID: PMC3228876)
81
Hong H, Benink HA, Zhang Y, Yang Y, Uyeda HT, Engle JW, Severin GW, McDougall MG, Barnhart TE, Klaubert DH, Nickles RJ, Fan F, Cai W. HaloTag: A novel reporter gene for positron emission tomography. American Journal of Translational Research, 2011, 3, 392-403. (PMCID: PMC3158741)
80
Cai W, Hong H. Peptoid and positron emission tomography: an appealing combination. American Journal of Nuclear Medicine and Molecular Imaging, 2011, 1, 76-79. (PMCID: PMC3183479)
79
Cai W, Zhang Y, Kamp TJ. Imaging of induced pluripotent stem cells: from cellular reprogramming to transplantation. American Journal of Nuclear Medicine and Molecular Imaging, 2011, 1,18-28. (PMCID: PMC3155258)
78
Zhang Y, Hong H, Cai W. Tumor-targeted drug delivery with aptamers. Current Medicinal Chemistry, 2011, 18, 4185-4194. (PMCID: PMC3205327)
77
Yang Y,* Zhang Y,* Hong H, Liu G, Leigh BR, Cai W. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 2066-2076. (PMCID: PMC3189267)
76
Hong H, Goel S, Zhang Y, Cai W. Molecular imaging with nucleic acid aptamers. Current Medicinal Chemistry, 2011, 18, 4195-4205. (PMCID: PMC3205285)
75
Shi J, Hong H, Ding Y, Yang Y, Wang F, Cai W, Wang X. Evolution of zinc oxide nanostructures through kinetics control. Journal of Materials Chemistry 2011,21, 9000-9008. (Inside Cover) (PMCID: PMC3130520)
74
Wang P, Yang Y, Hong H, Zhang Y, Cai W, D Fang. Aptamers as therapeutics in cardiovascular diseases. Current Medicinal Chemistry, 2011, 18, 4169-4174. (PMCID: PMC3205281)
73
Yang X, Hong H, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Xiao Y, Yang Y, Zhang Y, Nickles RJ, Cai W, Steeber DA, Gong S. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials, 2011,32, 4151-4160. (PMCID: PMC3292876)
72
Wang RE, Zhang Y, Cai J, Cai W, Gao T. Aptamer-based fluorescent biosensors. Current Medicinal Chemistry, 2011, 18, 4175-4184. (PMCID: PMC3205236)
71
Zhang Y, Hong H, Cai W. PET tracers based on Zr-89.Current Radiopharmaceuticals, 2011, 4, 131-139. (PMCID: PMC3205236)
70
Hong H,* Yang Y,* Zhang Y,* Engle JW, Barnhart TE, Nickles RJ, Leigh BR, Cai W. Positron emission tomography imaging of CD105 expression during tumor angiogenesis. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 1335-1343.(PMCID: PMC3105181)
69
Zhang Y, Yang Y, Cai W. Multimodality imaging of integrin αvβ3 expression. Theranostics, 2011, 1, 135-148. (PMCID: PMC3086621)
68
Zhang Y, Yang Y, Hong H, Cai W. Multimodality molecular imaging of CD105 (endoglin) expression. International Journal of Clinical and Experimental Medicine, 2011, 4, 32-42. (PMCID: PMC3048982)

 

2010

67
Hong H, Yang Y, Zhang Y, Cai W. Non-invasive cell tracking in cancer and cancer therapy. Current Topics in Medicinal Chemistry, 2010, 10, 1237-1248. (PMCID: PMC2916057)
66
Zhang Y, Hong H, Cai W. Imaging with Raman spectroscopy. Current Pharmaceutical Biotechnology, 2010, 11, 654-661. (PMCID: PMC2917525)
65 Hong H, Yang Y, Zhang Y, Cai W. Non-invasive imaging of human embryonic stem cells. Current Pharmaceutical Biotechnology, 2010, 11, 685-692. (PMCID: PMC2917512)
64 Hong H, Yang Y, Liu B, Cai W. Imaging of abdominal aortic aneurysm: the present and the future. Current Vascular Pharmacology, 2010, 8, 808-819. (PMCID: PMC2891873)
63 Hong H, Zhang Y, Cai W. In vivo imaging of RNA interference. Journal of Nuclear Medicine, 2010, 51, 169-172. (PMCID: PMC2832477)
62 Hong H, Zhang Y, Sun J, Cai W. Positron emission tomography imaging of prostate cancer. Amino Acids, 2010, 39, 11-27. (PMCID: PMC2883014)

 

2009

61 Hong H, Zhang Y, Sun J, Cai W. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today, 2009, 4, 399-413. (PMCID: PMC2753977)
60 Yang Y, Hong H, Zhang Y, Cai W. Molecular imaging of proteases in cancer. Cancer Growth and Metastasis, 2009, 2, 13-27. (PMCID: PMC2838618)
59 Hong H, Sun J, Cai W. Multimodality imaging of nitric oxide and nitric oxide synthases. Free Radical Biology & Medicine, 2009, 47, 684-698.(PMID: 19524664)
58 Hong H, Gao T, Cai W. Molecular imaging with single-walled carbon nanotubes. Nano Today, 2009, 4, 252-261. (PMCID: PMC3132891)

 

2008

57
Hong H, Sun J, Cai W. Radionuclide-based cancer imaging targeting the carcinoembryonic antigen. Biomarker Insights, 2008, 3, 435-451. (PMCID: PMC2688357)
56
Hong H, Sun J, Cai W. Anatomical and molecular imaging of skin cancer. Clinical, Cosmetic and Investigational Dermatology, 2008, 1, 1-17. (PMCID: PMC3048596)
55 Cai W, Kerner ZJ, Hong H, Sun J. Targeted cancer therapy with tumor necrosis factor-alpha. Biochemistry Insights, 2008, 1, 5-21.
54 Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnology, Science and Applications, 2008, 1, 17-32.
53 Cai W, Niu G, Chen X. Imaging of integrins as biomarkers for tumor angiogenesis. Current Pharmaceutical Design, 2008, 14, 2943-2973. (PMID: 18991712)
52 Cai W, Gambhir SS, Chen X. Molecular imaging of tumor vasculature. Methods in Enzymology, 2008, 445, 141-176.(PMID: 19022059)
51 Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. Journal of Nuclear Medicine, 2008, 49, 113S-128S. (PMID: 18523069)

 

Before UW-Madison

50
Cao F, Li Z, Lee A, Liu Z, Chen K, Wang H, Cai W, Chen X, Wu JC. Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. Cancer Research, 2009, 69, 2709-2713.
49
Cai W,* Guzman R,* Hsu AR, Wang H, Chen K, Sun G, Gera A, Choi R, Bliss T, He L, Li ZB, Maag ALD, Hori N, Zhao H, Moseley M, Steinberg GK, Chen X. Positron emission tomography imaging of post-stroke angiogenesis. Stroke, 2009, 40, 270-277.
48 Chen K,* Cai W,* Li ZB, Wang H, Chen X. Quantitative PET imaging of VEGF receptor expression. Molecular Imaging and Biology, 2009, 11, 15-22.
47 Veeravagu A, Liu Z, Niu G, Chen K, Jia B, Cai W, Jin C, Hsu AR, Connolly AJ, Tse V, Wang F, Chen X. Integrin αvβ3-targeted radioimmunotherapy of glioblastoma multiforme. Clinical Cancer Research, 2008, 14, 7330-7339.
46 Chen K, Li ZB, Wang H, Cai W, Chen X. Dual modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35, 2235-2244.
45 Cai W, Niu G, Chen X. Multimodality imaging of the HER-kinase axis in cancer. European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35, 186-208.
44 Cao Q, Cai W, Niu G, He L, Chen X. Multimodality imaging of IL-18-binding protein-Fc therapy of experimental lung metastasis. Clinical Cancer Research, 2008, 14, 6137-6145.
43 Liu Z, Davis C, Cai W, He L, Chen X, Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105, 1410-1415. (PMCID: PMC2234157)
42 Wang H, Chen K, Cai W, Li ZB, He L, Kashefi A, Chen X. Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein. Molecular Cancer Therapeutics, 2008, 7, 1044-1053. 
41 Veeravagu A, Hou LC, Hsu AR, Cai W, Greve JM, Chen X, Tse V. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model. Neurological Research, 2008, 30, 952-959.
40 Willmann JK, Chen K, Wang H, Paulmurugan R, Rollins M, Cai W, Wang DS, Chen IY, Gheysens O, Rodriguez-Porcel M, Chen X, Gambhir SS. Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation, 2008, 117, 915-922. 
39 Cai W, Chen X. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging. Nature Protocols, 2008, 3, 89-96.
38 Niu G, Cai W, Chen K, Chen X. Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor. Molecular Imaging and Biology, 2008, 10, 99-106.
37 Niu G, Cai W, Chen X. Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression. Frontiers in Bioscience, 2008, 13, 790-805.
36 Rodriguez-Porcel M, Cai W, Gheysens O, Willman JK, Chen K, Wang H, Chen IY, He L, Wu JC, Li ZB, Mohamedali KA, Kim S, Rosenblum MG, Chen X, Gambhir SS. Imaging of VEGF receptor in a rat myocardial infarction model using PET. Journal of Nuclear Medicine, 2008, 49, 667-673.
35 Cai W, Olafsen T, Zhang X, Cao Q, Gambhir SS, Williams LE, Wu AM, Chen X. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody. Journal of Nuclear Medicine, 2007, 48, 304-310.
34 Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small, 2007, 3, 1840-1854.
33 Wu Z, Li ZB, Chen K, Cai W, He L, Chin FT, Li F, Chen X. MicroPET of tumor integrin αvβ3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). Journal of Nuclear Medicine, 2007, 48, 1536-1544.
32 Cai W, Chen K, Li ZB, Gambhir SS, Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. Journal of Nuclear Medicine, 2007, 48, 1862-1870.
31 Wang H,* Cai W,* Chen K, Li ZB, Kashefi A, He L, Chen X. A new PET tracer specific for vascular endothelial growth factor receptor 2. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34, 2001-2010. 
30 Cai W,* Ebrahimnejad A,* Chen K, Cao Q, Li ZB, Tice DA, Chen X. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34, 2024-2036.
29 Cai W, Hsu AR, Li ZB, Chen X. Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Research Letters, 2007, 2, 265-281. 
28 Cai W, Chen X. Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression. Frontiers in Bioscience, 2007, 12, 4267-4279.
27 Cao Q,* Cai W,* Li ZB, Chen K, He L, Li HC, Hui M, Chen X. PET imaging of acute and chronic inflammation in living mice. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34, 1832-1842.
26 Li ZB, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X. 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor αvβ3 integrin expression. Journal of Nuclear Medicine, 2007, 48, 1162-1171.
25 Wu Z, Li ZB, Cai W, He L, Chin FT, Li F, Chen X. 18F-labeled mini-PEG spacered RGD dimer (183:07 PM 1/3/2012F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expression. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34, 1823-1831.
24 Veeravagu A, Hsu AR, Cai W, Hou LC, Tse VCK, Chen X. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy. Recent Patents on Anti-Cancer Drug Discovery, 2007, 2, 59-71.
23 Li ZB, Cai W, Chen X. Semiconductor quantum dots for in vivo imaging. Journal of Nanoscience and Nanotechnology, 2007, 7, 2567-2581.
22 Niu G, Xiong Z, Cheng Z, Cai W, Gambhir SS, Xing L, Chen X. In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Molecular Imaging and Biology, 2007, 9, 126-134.
21 Cai W,* Chen K,* He L, Cao Q, Koong A, Chen X. Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34, 850-858.
20 Hsu AR,* Cai W,* Veeravagu A, Mohamedali KA, Chen K, Vogel H, Hou LC, Tse VCK, Rosenblum MG, Chen X. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. Journal of Nuclear Medicine, 2007, 48, 445-454.
19 Liu Z,* Cai W,* He L, Nakayama N, Chen K, Sun X, Chen X, Dai H. In-vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice. Nature Nanotechnology, 2007, 2, 47-52. (Cited > 270 times)
18 Hsu AR, Veeravagu A, Cai W, Hou LC, Tse V, Chen X. Integrin αvβ3 antagonists for anti-angiogenic cancer treatment. Recent Patents on Anti-Cancer Drug Discovery, 2007, 2, 143-158.
17 Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. Journal of Nuclear Medicine, 2006, 47, 492-501.
16 Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, Chen X. Quantitative PET imaging of tumor integrin αvβ3 expression with 18F-FRGD2. Journal of Nuclear Medicine, 2006, 47, 113-121. 
15 Cao Q, Cai W, Li T, Yang Y, Chen K, Xing L, Chen X. Combination of integrin siRNA and irradiation for breast cancer therapy. Biochemical and Biophysical Research Communications, 2006, 351, 726-732.
14 Cai W,* Chen K,* Mohamedali KA, Cao Q, Gambhir SS, Rosenblum MG, Chen X. PET of vascular endothelial growth factor receptor expression. Journal of Nuclear Medicine, 2006, 47, 2048-2056.
13 Cai W, Rao J, Gambhir SS, Chen X. How molecular imaging is speeding up anti-angiogenic drug development. Molecular Cancer Therapeutics, 2006, 5, 2624-2633.
12 Cai W, Wu Y, Chen K, Cao Q, Tice DA, Chen X. In vitro and in vivo characterization of 64Cu-labeled AbegrinTM, a humanized monoclonal antibody against integrin αvβ3. Cancer Research, 2006, 66, 9673-9681.
11 Wu Y, Cai W, Chen X. Near-infrared fluorescence imaging of tumor integrin αvβ3 expression with Cy7-labeled RGD multimers. Molecular Imaging and Biology, 2006, 8, 226-236. (PMCID: PMC1643841)
10 Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Letters, 2006, 6, 669-676. (Cited > 300 times)
9 Cai W,* Zhang X,* Wu Y, Chen X. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide (18F-FBEM), and the synthesis of RGD peptide-based tracer for PET imaging of αvβ3 integrin expression. Journal of Nuclear Medicine, 2006, 47, 1172-1180. (PMCID: PMC1704081)
8 Cai W, Chen X. Anti-angiogenic cancer therapy based on integrin αvβ3 antagonism. Anti-cancer Agents in Medicinal Chemistry, 2006, 6, 407-428.
7 Cai W, Gambhir SS, Chen X. Multimodality tumor imaging targeting integrin αvβ3. BioTechniques, 2005, 39, S6-S17. 
6 Cai W, Taulane JP, Sorto NA, Oganesyan A,Gutierrez CG, Goodman M. Scaffold assembly of collagen-like triple helices at the C-terminus. Letters in Organic Chemistry, 2007, 4, 96-101.
5 Cai W, Wong D, Kinberger GA, Kwok SW, Taulane JP, Goodman M. Facile and efficient assembly of collagen-like triple helices on a TRIS scaffold. Bioorganic Chemistry, 2007, 35, 327-337.
4 Cai W, Kwok SW, Taulane JP, Goodman M. Metal-assisted assembly and stabilization of collagen-like triple helices. Journal of the American Chemical Society, 2004, 126, 15030-15031. 
3 Goodman M, Cai W, Kinberger GA. The new science of protein mimetics. Macromolecular Symposia, 2003, 201, 223-236.
2 Goodman M, Cai W, Smith ND. The bold legacy of Emil Fisher. Journal of Peptide Science, 2003, 9, 594-603. 
1 Kinberger GA, Cai W, Goodman M. Collagen mimetic dendrimers. Journal of the American Chemical Society, 2002, 124, 15162-15163. 

 

[ return to top ]